tiamulin have been reported. In this study, we evaluated the impact of tiamulin at 23 varying concentrations on the metabolism of B. pilosicoli using a 1 H-NMR-basedmetabonomics approach allowing the capture of the overall bacterial metabolic 25 response to antibiotic treatment. Based on growth curve studies, tiamulin impacted 26 bacterial growth even at very low concentration (0.008 µg/ml) although its metabolic 27 activity was barely affected 72 h post exposure to antibiotic treatment. Only the highest 28 dose of tiamulin tested (0.250 µg/ml) caused a major metabolic shift. Results showed 29 that below this concentration, bacteria could maintain a normal metabolic trajectory 30 despite significant growth inhibition by the antibiotic, which may contribute to disease 31 reemergence post antibiotic treatment. Indeed, we confirmed that B. pilosicoli remained 32 viable even after exposition to the highest antibiotic dose. This paper stresses the need 33 to ensure new evaluation of bacterial viability post bacteriostatic exposure such as 34 tiamulin to guarantee treatment efficacy and decrease antibiotic resistance 35 development. 36
37

Highlight
38
• B. pilosicoli metabolism was characterized using 1 H NMR-based metabonomics 39
• Tiamulin inhibited B. pilosicoli growth at very low dose (respectively < 0.016 40 2,2,3,3-d4 (TSP) as a 1 H NMR reference) and 0.5 ml of the solution was transferred into 122 5 mm of outer diameter NMR tubes. 1 H-NMR spectra were acquired on a Bruker Avance 123 DRX 700 MHz NMR Spectrometer (Bruker Biopsin, Rheinstetten, Germany) operating at 124 700.19 MHz and equipped with a cryogenic probe from the same manufacturer. A 125 standard 1-dimensional (1D) pulse sequence [recycle delay (RD)-90°-t1-90°-tm-90°-126 acquire free induction decay (FID)] with water suppression applied during RD of 2 s 127 and a mixing time (tm) of 100 ms and a 90° pulse set at 10 μs was applied. For each 128 spectrum 128 scans were recorded on a total of 32K data points. A broadening line 129 function of 0.3 Hz was used to multiply all FIDs. After acquisition, all spectra were 130 manually phased and baseline corrected using the software MestReNova® (version 131 2.1.8-11880, MestreLab, Spain). Finally, spectra were calibrated to the chemical shift of 132 TSP (δ 0.00). In order to facilitate metabolite identification based on literature, a series 133 of 2D spectra on selected samples were acquired using correlation spectroscopy (COSY) 134 NMR spectroscopy. 135 136
Statistical analysis 137
All spectra were scaled on unit variance and mean centered prior to analysis. To 138 evaluate metabolic variation between samples, principal component analysis (PCA) was 139 used. Orthogonal projection to latent structure discriminant analysis (O-PLS-DA) was 140 also performed, where 1 H-NMR spectra were used as a matrix of independent variables 141 Glucose was the only readily identifiable substrate that showed a reduction over time 166
( Figure 1C ). Decreased concentration of other substrates could not be detected and it is 167 possible that some may be below the detection limit of the NMR instrument. 168
Nevertheless, it is not unreasonable to assume that glucose was the only carbon source 169 used for bacterial anabolism and growth. B. pilosicoli and more especially the strainused for this experiment (B2904) is able to use a wide range of carbohydrates and 171 hexoses as primary carbon sources [10] but it would seem in this study that glucose was 172 used preferentially. 173 174
Tiamulin impacts B. pilosicoli growth even at very low doses 175
Having characterized the metabolic footprint of B. pilosicoli when grown in optimal 176 conditions, we then challenged it with increasing tiamulin doses. Tiamulin impacted B. pilosicoli colony formation on agar plates (Supplement Table 1 ). These results indicate 220 that B. pilosicoli is able to recover from tiamulin exposure (even at the highest dose of 221 0.250 µg/mL) once back in optimal growth conditions. 222 were also able to secrete butyric acid but not propionic acid. Both of these short chain 231 fatty acids were found to be potential carbon sources for B. pilosicoli [10] . Bacteria also 232 released a large number of amino acids that could be caused either by synthesis and 233 active secretion of these amino acids, or more likely due to exogenous protein 234 degradation. This result is in accordance with the genetic results published by Mappley 235 et al. [10] that indicated a strong proteolytic capacity of the bacterium. This specific 236 strain of B. pilosicoli was also shown to be able to use amino acids as primary carbon 237 source [10] . However, as the bacterium favors glucose if available as primary carbon 238 source, amino acids may here only be used for protein synthesis and may therefore 239 become in excess in the culture medium where they accumulate. Finally, the bacteria 240 secreted TMA. Gut bacteria generally produce TMA from dietary L-carnitine, betaine or 241
choline. Yet, it was not possible to detect a decrease in concentration of these 242 compounds indicating that B. pilosicoli might not use these molecules as precursors or 243 that the technique used was not sensitive enough to detect such variations. one log in comparison to control. However, the metabolic trajectories observed by the 263 media were identical. Indicating that tiamulin was able to impact growth but that B. 264 pilosicoli basic metabolism remained unaffected. Higher doses were able to reduce but 265 not silent B. pilosicoli metabolism despite complete growth inhibition. Furthermore, the 266 metabolism of B. pilosicoli appears to slightly recover from all tiamulin concentrations 267 except from 0.250 µg/ml after 120 h of growth. This might be due to the apparition of 268 resistance, which is known as being a slow bacterial development process [34, 35] .
In addition, it was demonstrated that B. pilosicoli was able to survive post-tiamulin 270 exposure even at the highest antibiotic dose when plated on agar (after 120 h drug 271 exposure). Indeed B. pilosicoli colonies were identified 48h after the end of the 272
antibiotic treatment for all doses tested (0.008-0.250 µg/mL). These results illustrate 273 the potential of B. pilosicoli to enter a dormancy state when exposed to tiamulin that is 274 reversible once the treatment period is over. 275
Besides, results demonstrated a slow response of the bacteria to antibiotic treatment as 276 modification of the metabolic footprint was only observed after more than 48 h of 277 growth in presence of tiamulin. From these results, it seems that metabolism was 278 stressed during the exponential phase, when bacterial division is compromised. 279
Metabolism modification was mainly associated with increased amino acid 280 consumption (that were produced in the control). However, as the provenance of these 281 amino acids remains unclear, two hypotheses can be formulated. Firstly, in response to 282 antibiotic stress bacteria could use amino acids as alternative energy substrates. 283
Secondly, B. pilosicoli might not be able to hydrolyse proteins present in the media 284 because new protein synthesis, such as secreted proteases, is blocked at the ribosome. 285
The specificity of the amino acids used indicates the first option is the most probable 286 and that catabolism repression could be overridden to secure energy from multiple 287 sources. This is an interesting hypothesis that needs confirmation by alternative 288 techniques such as transcriptomics. 289
The fact that B. pilosicoli remain viable and metabolically active without dividing despite 290 the antibiotic treatment and is able to recover after antibiotic exposure could partly 291 explain the IS relapse observed in farms after tiamulin intervention. Indeed, it seems to 292 arise from these results that bacteria remain viable but are not able to divide entering 293 therefore a dormancy stage. It is highly possible that such phenomenon occurs in the 294 intestinal lumen, where bacteria could suffer from inactivation of cell division but 295 remain viable. This bacterial state might be associated with a decrease in their 296 pathogenicity explaining the disappearance of associated symptoms. Nevertheless, 297 bacteria might remain viable but at a "dormancy" state in the intestinal lumen or animal 298 faeces until the environment becomes less hostile (end of antibiotic treatment) when 299 they can recover their pathogenic property. However, it is impotent to point out that 300 here B. pilosicoli was recovered on agar plates that represent optimal growth 301 conditions. This might not be the case in the intestinal lumen that is a more hostile 302 environment when the bacterium also needs to compete with other commensal bacteria 303
and is confronted to the host's immune system. 304
As increasing antibiotic resistance mechanisms developed by pathogenic bacteria are 305 arising, many studies and reviews have stressed the concerns linked to inappropriate 306 antibiotic usage. Indeed, this is strongly linked to development of antibiotic resistance, a 307 burden for health and industry. There is therefore a surge for redefining appropriate 308 antibiotic use that would help minimizing the current concern linked to decreased 309 antibiotic efficiency. Thus, importance should be given to new methods development 310 aiming at better assessing antibiotic efficiency and to detect potential antibiotic 311 resistance factor development. This study indicates that metabonomics could be and 312 easy and practical way to evaluate bacterial metabolic activity and therefore assess 313 antibiotic efficiency to totally inactivate pathogens and therefore avoid infection 314 relapse. 315 316
Conclusion
317
This work gave a clearer understanding of B. pilosicoli metabolism in optimum growth 318 conditions, including indication regarding favored fermentation pathways and aminoacids metabolism. It supports the fact that tiamulin can inhibit efficiently bacterial 320 growth at low concentrations. However, it was surprising to observe that tiamulin could 321 impact B. pilosicoli growth without influencing its basic metabolism. It also reveals that 322 the bacterium try to maintain metabolic homeostasis despite an obvious stress visible 323 on the growth curve, demonstrating that in response to xenobiotic stress, bacterial 324 division is the first mechanism to be suspended. This indicates that tiamulin might 325 present a good solution against AIS outbreaks, as it is able to significantly reduce or stop 326 bacterial growth, provided that the efficient dose is achieved in the gut of every 327 individual. Even so, the treatment may not be sufficient to avoid relapse of the disease. 328
Such findings suggest that measurement of bacterial activity might be needed in order 329 to assess antibiotic efficiency against potential reoccurrence of the disease. In that 330 prospect, metabonomics appeared as a potential solution to evaluate if antibiotic 331 treatment can inactivate microbial metabolic activity. 332 333
